← Eichor
Study identifier: NCT06437132 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Decoding Death and Dying in People With Dementia by Digital Thanotyping

Condition: Dementia  ·  Sponsor: University of Bergen

PhaseN/A
Planned participants480
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

How can healthcare professionals recognize that a person with dementia is at the end of life? When people are dying, their physical, mental, and social abilities are gradually declining. No reliable method of predicting perceived dying currently exists although the technology is available (sensors, algorithms). The aim of Decoding Death and Dying in Dementia by Digital thanotyping (5-D) is to provide methods and tools to diagnose and describe dying to an unprecedented level of accuracy and robustness, within a timespan larger than is possible now, focusing on the case of dying people with dementia as one of the most vulnerable and difficult to study groups. 5-D combines clinical assessment tools with wearable sensing technology to monitor a) pain and distressing symptoms, b) behavioral and psychological symptoms in dementia (BPSD), c) oral changes, and to decode "the point of no return" as the beginning of perceived dying. To obtain this outcome in nursing home patients with dementia, the investigator will test the main hypothesis: from monitoring the evolution of thanotype components over time and their interdependencies, the prediction of the "point of no return" is possible. The objectives of 5-D are: O1. Collect data using sensors and validated assessment scales. O2. Develop estimation methods for BPSD from sensor measurements. O3. Develop digital tools to capture the expression of pain. O4. Determine the relationship between breathing and oral symptoms. O5. Develop mo…

This description comes directly from the study's public registry record.

Talk to the study team

Bettina S. Husebø, PhD  ·  48094660  ·  bettina.husebo@uib.no

Monica Patrascu, PhD  ·  91198669  ·  monica.patrascu@uib.no

Always discuss trial participation with your own doctor first.

Locations (1)

Bergen Røde Kors Sykehjem ASBergen, Vestland, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06437132